deoxypyridinoline has been researched along with goserelin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caird, LE; Gow, SM; Hannan, WJ; Lumsden, MA; West, CP | 1 |
| Amama, EA; Minaguchi, H; Taga, M | 1 |
| Bryant, C; Campbell, J; Diamond, T; Lynch, W | 1 |
| Kiesel, L; Parviz, M; Runnebaum, B; Seibel, MJ; Sillem, M; Ulrich, U; von Holst, T; Woitge, HW; Ziegler, R | 1 |
| Duncan, WE; Harding, P; Howard, RS; McLeod, DG; Preston, DM; Torréns, JI | 1 |
2 trial(s) available for deoxypyridinoline and goserelin
| Article | Year |
|---|---|
Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability.
Topics: Adult; Amino Acids; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms; Uterus | 1997 |
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Density; Bone Remodeling; Double-Blind Method; Endometriosis; Female; Goserelin; Humans; Kinetics; Medrogestone; Osteocalcin; Osteoporosis; Placebos; Premenopause; Progesterone Congeners | 1999 |
3 other study(ies) available for deoxypyridinoline and goserelin
| Article | Year |
|---|---|
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeling; Buserelin; Collagen; Collagen Type I; Endometriosis; Estradiol; Female; Goserelin; Humans; Hydroxyproline; Leiomyoma; Osteocalcin; Peptides; Retrospective Studies | 1998 |
The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Bone Density; Calcium; Carcinoma; Drug Administration Schedule; Etidronic Acid; Evaluation Studies as Topic; Femur Neck; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Testosterone; Tomography, X-Ray Computed; Vitamin D | 1998 |
Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Topics: Absorptiometry, Photon; Adenocarcinoma; Aged; Amino Acids; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Remodeling; Calcium; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2002 |